Statins may lower the risk of ovarian cancer
Scientists from the University of Bristol have found a potential connection between the intake of statins and a reduction in ovarian cancer risk...
BioNews
118 articles
Podcast Review: The Dangers of DIY Genetic Testing (Science Weekly, The Guardian)
By 2022 the world's consumer genetic testing market is expected to quadruple to £200 million, according to The Guardian. But while the popularity of DIY genetic testing has undergone huge expansion in recent years, doctors and scientists have called for a crackdown on tests offered by consumer genetics companies such as 23andMe and AncestryDNA...
Health reports from direct-to-consumer genetic tests 'woefully incomplete'
Direct-to-consumer genetic tests should not be used as a basis for medical decision making, according to two separate studies released last week...
Blood test detects ovarian cancer two years earlier
Scientists have developed a blood test that may be able to detect ovarian cancer up to two years earlier than other methods...
Widen breast cancer gene screening, says US taskforce
An influential health group in the USA has concluded that more women could benefit from wider gene screening for hereditary breast or ovarian cancer...
NHS approves earlier use of 'game-changing' ovarian cancer drug
Women in England with advanced ovarian cancer will now have access to a drug that could help halt the progression of their disease much earlier in their course of treatment...
Lack of vaginal bacteria linked to ovarian cancer
Women who have fewer protective bacteria in the vagina may be at increased risk of developing ovarian cancer, according to new research...
Irish hospital reviews its cancer test reports after error in case
A hospital in Ireland has been reviewing hundreds of test reports for the BRCA gene after a woman was incorrectly told she was not at heightened risk of cancer...
Ovarian cancer drug olaparib slows recurrence and cuts deaths
A drug to treat ovarian cancer has shown promising results in a clinical trial, delaying signs of relapse and reducing chances of death. The drug olaparib, a PARP inhibitor, was used in patients with BRCA-mutated advanced ovarian cancer...
Huntington's protein is 'super assassin' for cancer cells
Researchers have discovered that the protein responsible for the development of Huntington's disease is highly toxic to cancer cells...